ライフサイエンスコーパス: nuclear factor-kappa B

1 tivated protein kinases as well as NFkappaB (nuclear factor kappa B).

2 ak1 (p21-activated kinase -1) --> NF-kappaB (nuclear factor-kappa B).

3 -1, tribbles 3, reactive oxygen species, and nuclear factor kappa B)?

4 s both C and T alleles were found to bind to nuclear factor kappa B.

5 phosphorylation and nuclear translocation of nuclear factor kappa B.

6 opolysaccharide (LPS) -induced activation of Nuclear Factor kappa B.

7 togen-activated protein kinase and activates nuclear factor kappa B.

8 n of both interferon regulatory factor 3 and nuclear factor kappa B.

9 bition of glycogen synthase kinase-3beta and nuclear factor kappa B.

10 D91 triggers signalling cascades to activate nuclear factor-kappa B.

11 rivative of dithiocarnamate, an inhibitor of nuclear factor- kappa B.

12 hanism for induction of CDX2 is dependent on nuclear factor kappa B, a crucial transcription factor i

13 Inflammatory super enhancers formed by nuclear factor-kappa B accumulate at the expense of imme

14 ced persistent inflammation by circumventing nuclear factor kappa B activation and its downstream cyt

15 bic acid and dehydroascorbic acid attenuated nuclear factor kappa B activation and normalized coagula

16 lar signal-regulated kinase 1 and 2-mediated nuclear factor kappa B activation in mice.

17 e course plots of Lipopolysaccharide-induced Nuclear Factor kappa B activation in mouse embryo fibrob

18 ardiac mitochondrial respiratory efficiency, nuclear factor kappa B activation, and caspase activitie

19 y include molecular interactions upstream of Nuclear Factor kappa B activation.

20 nhibited tumor necrosis factor-alpha induced nuclear factor-kappa B activation by 27.5% at 2 mg/ml, w

21 cyclophosphamide with mecamylamine suggested nuclear factor-kappa B activation in the chronic inflamm

22 tinamide effectively attenuated postischemic nuclear factor-kappa]B activation and exhibited robust a

23 ects that were accompanied by a reduction in nuclear factor kappa B activity and cell surface levels

24 ecrease in hepatic fibrosis (p < 0.001), and nuclear factor-kappa B activity (p < 0.05) as compared w

25 LPS-induced nuclear factor kappa B, Akt, and p38 activation is enhan

26 location of transcription factors, including nuclear factor kappa B, although its role in PCa was lar

27 mitogen-activated protein (MAP) kinases and nuclear factor kappa B and decreased myogenic differenti

28 ecule 1-dependent and leads to activation of nuclear factor kappa B and extracellular signal-regulate

29 nate attenuated the HS-induced activation of nuclear factor kappa B and reduced the expression of pro

30 itions, interferonopathies, and disorders of nuclear factor kappa B and/or aberrant TNF activity.

31 Immunofluorescence showed colocalization of nuclear factor kappa-B and OCN in diseased and normal va

32 crosis factor alpha]), as well as NF-kappaB (nuclear factor kappa B) and inflammasome activation.

33 reby enabling constitutive activation of the nuclear factor-kappa B, and contributing to chronic infl

34 ity of activated glucocorticoid receptor and nuclear factor kappa-b appeared to join pre-existing P30

35 es were associated with increased NF-kappaB (nuclear factor kappa B) binding activity and expression

36 tein, osteoprotegerin, receptor activator of nuclear factor kappa B, bone morphogenic protein 2, and

37 Our data demonstrate that miR-146a controls nuclear factor kappa B-dependent inflammatory responses

38 ing LTR-driven HIV-1 gene transcription in a nuclear factor kappa B-dependent manner.

39 insulin receptor, which in turn activates a nuclear factor kappa B-dependent metabolic pathway, lead

40 (Hz), signals NOS induction through ERK- and nuclear factor kappa B-dependent pathways and has been d

41 human peripheral blood mononuclear cells and nuclear factor kappa B-dependent transcription in human

42 sponse genes, pointing to the suppression of nuclear factor kappa B-dependent transcription.

43 Cellular activation was assessed by nuclear factor-kappa B-driven luciferase activity, cytok

44 t HEK293 cells, HEK293-TLR2 cells had marked nuclear factor-kappa B-driven luciferase activity, had m

45 in inflammatory and cancer pathways, such as nuclear factor kappa B, EGF, Wnt, and B-cell lymphoma 2.

46 NF-kappaB (nuclear factor kappa B) family transcription factors are

47 ee text] ([Formula: see text]) signaling via nuclear factor kappa-B ([Formula: see text]) hallmarks (

48 The effects of CLIC4 on NF-kappaB (nuclear factor-kappa B), HIF (hypoxia-inducible factor),

49 and III IFN responses, such as inhibitor of nuclear factor kappa B (IkappaB) kinase alpha (IKKalpha)

50 six cytokines that regulate the activity of nuclear factor kappa B in 293T cells.

51 nhibitor PD98059, the Src inhibitor pp2, the nuclear factor- kappa B inhibitor caffeic acid phenethyl

52 In vivo administration of a nuclear factor-kappa B inhibitory peptide, NBD, blocked

53 crovascular density and higher expression of nuclear factor kappa B, interleukin-6, interleukin-8, tr

54 ylated and thereby inhibited by inhibitor of nuclear factor kappa B kinase subunit beta (IKKbeta) to

55 howed that Hsp90 interacts with inhibitor of nuclear factor kappa-B kinase (IKK) together with cochap

56 Pharmacological inhibition of inhibitor of nuclear factor kappa-B kinase subunit beta (IKKbeta), bu

57 Nuclear Factor Kappa B levels were increased in BAT, whe

58 ncreased expression of receptor activator of nuclear factor kappa B ligand (RANK-L) due to pro-inflam

59 Serum receptor activator of nuclear factor kappa B ligand (RANKL) and its antagonist

60 Receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegeri

61 on and inactivation of Receptor Activator of Nuclear factor Kappa B Ligand (RANKL) and osteoprotegeri

62 clast (OC) response to receptor activator of nuclear factor kappa B ligand (RANKL) and thus bone meta

63 osis factor (TNF), and receptor-activator of nuclear factor kappa B ligand (RANKL) were significantly

64 one marrow cultures to receptor activator of nuclear factor kappa B ligand (RANKL), macrophage colony

65 nonoclonal antibody to receptor activator of nuclear factor kappa B ligand, has completed its major f

66 nsing receptor and the receptor activator of nuclear factor kappa B ligand/receptor activator of nucl

67 that stimulation with receptor activator of nuclear factor kappa-B ligand (RANKL) resulted in a robu

68 oxidase (MPO), and the cytokine receptor for nuclear factor kappa-B ligand (RANKL) were significantly

69 igated if ILCs express receptor activator of nuclear factor kappa-B ligand (RANKL), a cytokine crucia

70 ze salivary levels of receptor activator for nuclear factor kappa-B ligand (RANKL), osteoprotegerin,

71 ted T cells to produce receptor activator of nuclear factor kappa-B ligand (RANKL), which, in turn, p

72 TNF-alpha), as well as receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast

73 tal tissue and induces receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK-osteoproteger

74 human monoclonal anti-receptor activator of nuclear factor kappa-B ligand antibody, with zoledronic

75 Change in circulating receptor activator of nuclear factor kappa-B ligand was higher in the interven

76 chemotactic protein 1, receptor activator of nuclear factor kappa-B ligand, and macrophage colony-sti

77 ctivator-related gene, receptor activator of nuclear factor kappa-B ligand, and osteoblast differenti

78 lcin, osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, vascular endothelial grow

79 factor (TNF)-alpha and receptor activator of nuclear factor kappa-B ligand; these cytokines were also

80 issue homogenates, and receptor activator of nuclear factor-kappa B ligand (RANKL) activation was ana

81 s and osteoclasts, and receptor activator of nuclear factor-kappa B ligand (RANKL) activity.

82 , expression of activated receptor activator nuclear factor-kappa B ligand (RANKL) and bone density i

83 The receptor activator of nuclear factor-kappa B ligand (RANKL) inhibitor osteopro

84 ) PBMCs was induced by receptor activator of nuclear factor-kappa B ligand (RANKL), either alone or i

85 osteoprotegerin (OPG)/receptor activator of nuclear factor-kappa B ligand (RANKL), increased osterix

86 histochemistry for the receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin (

87 ranscription factor-2, receptor activator of nuclear factor-kappa B ligand (RANKL), sclerostin, and D

88 LR-4, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand (RANKL), tumor necrosis fa

89 ing factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL).

90 osorbent assay for: 1) receptor activator of nuclear factor-kappa B ligand (RANKL); 2) osteoprotegeri

91 (IL)-6, IL-8, soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), osteoprotegerin

92 mmunoreactivity to the receptor activator of nuclear factor-kappa B ligand at day 7 post-treatment, s

93 nuclear factor-kappa B-receptor activator of nuclear factor-kappa B ligand interaction for osteoclast

94 interleukin-1beta and receptor activator of nuclear factor-kappa B ligand than group EP-HN019 (P <0.

95 tegerin and decreasing receptor activator of nuclear factor-kappa B ligand.

96 lectrophoresis; RANKL, receptor activator of nuclear factor kappa B-ligand; NFATc1, nuclear factor of

97 eraction with cyclooxygenase-2 (COX-2), p65- nuclear factor kappa B, lipoxygenase-1 (LOX-1) and toll-

98 eracting protein 2) to coordinate NF-kappaB (nuclear factor kappa B)-mediated cytokine responses.

99 ulting in de novo lipogenesis, and increased nuclear factor kappa B-mediated inflammation act in conc

100 enomena at the organismal level, we assessed nuclear factor kappa B (NF-kappaB) activation (indicativ

101 ction in cultured hepatoma cells, leading to nuclear factor kappa B (NF-kappaB) activation and the pr

102 Because cIAP-1 and cIAP-2 also promote nuclear factor kappa B (NF-kappaB) activation by the can

103 ogesterone exhibited an inhibitory effect on nuclear factor kappa B (NF-kappaB) activation following

104 intestinal epithelial cells and also induced nuclear factor kappa B (NF-kappaB) activation in HEK293T

105 Nuclear factor kappa B (NF-kappaB) activation in the liv

106 T-cell proliferation, T-cell subsests, nuclear factor kappa B (NF-kappaB) activation, and Bax a

107 at least three different pathways leading to nuclear factor kappa B (NF-kappaB) activation, apoptosis

108 atterns of c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappaB) activation.

109 One potential mechanism is to suppress nuclear factor kappa B (NF-kappaB) activation.

110 f the most prevalent being the disruption of nuclear factor kappa B (NF-kappaB) activation.

111 cells, especially those cells dependent upon nuclear factor kappa B (NF-kappaB) activation.

112 the expression of genes reflecting enhanced nuclear factor kappa B (NF-kappaB) activity were noted i

113 r 4), interferon regulatory factor-3 (IRF3), nuclear factor kappa B (NF-kappaB) activity, and proinfl

114 ecific lipin-1 deficiency diminished hepatic nuclear factor kappa B (NF-kappaB) activity, limited liv

115 RF triggered a high but nonsustained peak of nuclear factor kappa B (NF-kappaB) activity.

116 uclear export sequence (NES) of inhibitor of nuclear factor kappa B (NF-kappaB) alpha (IkappaBalpha)

117 alyses across technologies demonstrated that nuclear factor kappa B (NF-kappaB) and cholesterol biosy

118 Both the canonical nuclear factor kappa B (NF-kappaB) and mitogen activated

119 The Rel-like transcription factors nuclear factor kappa B (NF-kappaB) and the calcineurin-d

120 The transcription factor nuclear factor kappa B (NF-kappaB) and the long non-codi

121 Nuclear factor kappa B (NF-kappaB) and type 1 interferon

122 -protein interaction (PPI) interface between nuclear factor kappa B (NF-kappaB) essential modulator (

123 TNF-alpha and phospho-nuclear factor kappa B (NF-kappaB) expression in ocular

124 TRF also showed a greater inhibition on the nuclear factor kappa B (NF-kappaB) expression than T and

125 alling pathways leading to activation of the nuclear factor kappa B (NF-kappaB) family of transcripti

126 The nuclear factor kappa B (NF-kappaB) family of transcripti

127 e expression by transcription factors of the nuclear factor kappa B (NF-kappaB) family.

128 The transcription factor nuclear factor kappa B (NF-kappaB) has been implicated i

129 Constitutive activation of nuclear factor kappa B (NF-kappaB) has been linked with

130 a 12,14- Prostaglandin J2 (15dPGJ2) inhibits Nuclear factor kappa B (NF-kappaB) in human myocytes and

131 The role of nuclear factor kappa B (NF-kappaB) in oxidative stress,

132 The role of nuclear factor kappa B (NF-kappaB) in the glucose-mediat

133 A20, a potent antiinflammatory and nuclear factor kappa B (NF-kappaB) inhibitory protein, h

134 The nuclear factor kappa B (NF-kappaB) intracellular signall

135 Nuclear factor kappa B (NF-kappaB) is a key mediator of

136 The transcription factor nuclear factor kappa B (NF-kappaB) is activated in human

137 Nuclear factor kappa B (NF-kappaB) is an inducible trans

138 We utilized a transgenic mouse model where nuclear factor kappa B (NF-kappaB) is selectively inhibi

139 mily members such as p38 and JNK and induced nuclear factor kappa B (NF-kappaB) pathway activation.

140 The alternative or noncanonical nuclear factor kappa B (NF-kappaB) pathway regulates the

141 (IL)12 or IL18 as well as inhibition of the nuclear factor kappa B (NF-kappaB) pathway reversed NK c

142 ) 3' untranslated region (UTR) and activates nuclear factor kappa B (NF-kappaB) pathways that contrib

143 cycle progression and I-kappa B kinase (IKK)/nuclear factor kappa B (NF-kappaB) signaling contributes

144 MRV miRNAs, we screened for their effects on nuclear factor kappa B (NF-kappaB) signaling in the pres

145 biquitinated chains from key proteins in the nuclear factor kappa B (NF-kappaB) signaling pathway.

146 Nuclear factor kappa B (NF-kappaB) signaling plays criti

147 The nuclear factor kappa B (NF-kappaB) signaling system, a k

148 We used a chick in vivo model to investigate nuclear factor kappa B (NF-kappaB) signaling, a critical

149 active and supports TGF-beta-induced EMT and nuclear factor kappa B (NF-kappaB) signaling, whereas th

150 te/macrophage function through inhibition of nuclear factor kappa B (NF-kappaB) signaling.

151 Here we demonstrate that the dynamics of Nuclear Factor kappa B (NF-kappaB) signalling and the ce

152 or endoplasmic reticulum stress and initiate nuclear factor kappa B (NF-kappaB) signalling.

153 DNA binding activity of nuclear factor kappa B (NF-kappaB) that transactivates m

154 CD47 expression was found to be regulated by nuclear factor kappa B (NF-kappaB) through a specific re

155 Nuclear factor kappa B (NF-kappaB) transcription factors

156 phate (NAD(P)H)-oxidase and translocation of nuclear factor kappa B (NF-kappaB) were also evaluated.

157 Antagonists of nuclear factor kappa B (NF-kappaB), cyclooxygenase pathw

158 immune pathways that are primarily driven by nuclear factor kappa B (NF-kappaB), interferon regulator

159 acts as an upstream activator of astroglial nuclear factor kappa B (NF-kappaB), leading to the relea

160 ase for p27(Kip1), through activation of p52 nuclear factor kappa B (NF-kappaB)-2.

161 rophages enhance myofibroblast survival in a nuclear factor kappa B (NF-kappaB)-dependent manner and

162 Here we identified hepatic nuclear factor kappa B (NF-kappaB)-inducing kinase (NIK)

163 Nuclear factor kappa B (NF-kappaB)-mediated transcriptio

164 p65, the transcriptionally active subunit of nuclear factor kappa B (NF-kappaB).

165 quired for API2-MALT1 to stimulate canonical nuclear factor kappa B (NF-kappaB).

166 and identified binding sites for GATA-6 and nuclear factor kappa B (NF-kappaB).

167 location and transcriptional activity of the nuclear factor kappa B (NF-kappaB).

168 6 (SETD6) monomethylates the RelA subunit of nuclear factor kappa B (NF-kappaB).

169 ated the hepatocellular damage by inhibiting nuclear factor kappa B (NF-kappaB)/cyclooxygenase 2 sign

170 factor activity [myocyte enhancer factor-2, nuclear factor kappa B (NF-kappaB)].

171 decrease in PKC activity, and inhibition of nuclear factor kappa B (NF-kB) translocation, were attri

172 CARD14 activates nuclear factor kappa B (NF-kB), and compared with wild-t

173 glucocorticoid insensitivity: respectively, nuclear factor kappa B (NF-kB), cAMP response element-bi

174 cluding TNF-alpha and IL-6 and activation of nuclear factor kappa B (NF-kB/p65), p38 mitogen-activate

175 Nuclear factor kappa-B (NF-kappaB) activation and produc

176 gulators linked to TNF-alpha/TNFR signaling, nuclear factor kappa-B (NF-kappaB) activation, autophagy

177 ll receptor (BCR) signaling and constitutive nuclear factor kappa-B (NF-kappaB) activation, which is

178 response element-binding protein (CREB) and nuclear factor kappa-B (NF-kappaB) are two ubiquitous tr

179 ron regulatory factor 3 (IRF-3)-mediated and nuclear factor kappa-B (NF-kappaB) inhibitor (IkappaBalp

180 NOS1 is complex but recent data suggest that nuclear factor kappa-B (NF-kappaB) is an important trans

181 recent Immunity articles probe the roles of Nuclear Factor kappa-B (NF-kappaB) pathways in survival

182 egulated kinase (ERK), calcium (Ca(2+)), and nuclear factor kappa-B (NF-kappaB) pathways, response dy

183 Here, we identify a role for the Nuclear Factor kappa-B (NF-kappaB) signaling pathway in

184 transcripts and an increase in inhibitors of nuclear factor kappa-B (NF-kappaB) signaling, possibly i

185 Nuclear factor kappa-B (NF-kappaB), a key downstream pla

186 dly induces co-occupancy of KDM7A and UTX at nuclear factor kappa-B (NF-kappaB)-associated elements i

187 Nuclear factor kappa-B (NF-kappaB)-regulated inflammator

188 (residues 67-206), the primary inhibitor of nuclear factor kappa-B (NF-kappaB).

189 ion of RelA (p65), thus repressing oncogenic nuclear factor kappa-B (NF-kB) signaling and inducing ap

190 ad of colonic tumors and increased STAT3 and nuclear factor-kappa B (NF-kappaB) activation in colon.

191 d mitogen-activated protein (MAP) kinase and nuclear factor-kappa B (NF-kappaB) activation, and the s

192 Notch-1 can increase nuclear factor-kappa B (NF-kappaB) activity through a va

193 The nitric oxide concentration and nuclear factor-kappa B (NF-kappaB) activity were measure

194 carcinoma cells (T24 cells), and TPA-induced nuclear factor-kappa B (NF-kappaB) activity with human h

195 idermis of mice lacking transcription factor nuclear factor-kappa B (NF-kappaB) activity, primary hai

196 the activation of the transcription factors nuclear factor-kappa B (NF-kappaB) and activator protein

197 ed PHB expression on TNF-alpha activation of nuclear factor-kappa B (NF-kappaB) and epithelial barrie

198 ithelia in Hashimoto's thyroiditis activates nuclear factor-kappa B (NF-kappaB) and induces pro-infla

199 GF), inducible nitric oxide synthase (iNOS), nuclear factor-kappa B (NF-kappaB) and intercellular adh

200 The transcription factor nuclear factor-kappa B (NF-kappaB) and mitogen-activated

201 The decline in the activation of nuclear factor-kappa B (NF-kappaB) and p38 mitogen-activ

202 genotoxic and oncogenic stress activates the nuclear factor-kappa B (NF-kappaB) and p53 proteins; how

203 amic interplay of two transcription factors, nuclear factor-kappa B (NF-kappaB) and peroxisome prolif

204 UPR, there was transcriptional regulation by nuclear factor-kappa B (NF-kappaB) and RNA stabilization

205 t-7b cluster and identified several putative nuclear factor-kappa B (NF-kappaB) consensus elements.

206 The nuclear factor-kappa B (NF-kappaB) family of transcripti

207 tion of proinflammatory transcription factor nuclear factor-kappa B (NF-kappaB) in 7-week-old mdx mic

208 At concentrations that activated nuclear factor-kappa B (NF-kappaB) in LUHMES cells, EMA

209 imately 40,000 genes, and tested the role of nuclear factor-kappa B (NF-kappaB) in maintaining an act

210 ic proteins and the proinflammatory molecule nuclear factor-kappa B (NF-kappaB) in the retina of Lewi

211 Nuclear factor-kappa B (NF-kappaB) is a key transcriptio

212 we have shown that the transcription factor nuclear factor-kappa B (NF-kappaB) is activated by BCR-A

213 affects expression of receptor activator of nuclear factor-kappa B (NF-kappaB) ligand (RANKL), a pot

214 Constitutive activation of the nuclear factor-kappa B (NF-kappaB) pathway is a hallmark

215 constitutive activation of the antiapoptotic nuclear factor-kappa B (NF-kappaB) pathway, which can in

216 ne of these main signaling mechanisms is the nuclear factor-kappa B (NF-kappaB) pathway, which integr

217 f myeloid cells, are partly regulated by the nuclear factor-kappa B (NF-kappaB) pathway.

218 PGE(2) and the transcription factor nuclear factor-kappa B (NF-kappaB) regulate IL-1beta-sti

219 d activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-kappaB) signaling in Lilrb3(-

220 D137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-kappaB) signaling in tumor ce

221 dy, we show that the activation of classical nuclear factor-kappa B (NF-kappaB) signaling increases t

222 nvading pathogens, their ability to regulate nuclear factor-kappa B (NF-kappaB) signaling, interleuki

223 IL-6 expression is regulated by the nuclear factor-kappa B (NF-kappaB) transcription factor,

224 AT3, c-jun n-terminal kinases (JNK), EKR1/2, nuclear factor-kappa B (NF-kappaB)) in the gastrocnemius

225 Nuclear factor-kappa B (NF-kappaB), a master regulator o

226 eading to activation of transcription factor nuclear factor-kappa B (NF-kappaB), which is a central r

227 like receptor 4 (TLR4)-dependent pathway via nuclear factor-kappa B (NF-kappaB), while simultaneously

228 so stimulated IFN-beta promoter activity and nuclear factor-kappa B (NF-kappaB)-dependent transcripti

229 einase (MMP)-1, as well as the activation of nuclear factor-kappa B (NF-kappaB).

230 tes exhibited spontaneous hyperactivation of nuclear factor-kappa B (NF-kappaB).

231 We exploited the Nuclear Factor-kappa B (NF-kB) signal transduction pathw

232 and activator of transcription 3 (STAT3) and nuclear factor-kappa B (NF-kB).

233 cell cycle and prosurvival pathways (such as nuclear factor kappa B [NF-kappaB], AKT), pathways regul

234 monstrated a signaling pathway from HIF-1 to nuclear factor kappa B (NFkappaB) activation to enhanced

235 Furthermore, when TGFbeta1-induced nuclear factor kappa B (NFkappaB) activation was inhibit

236 f intrapancreatic trypsinogen activation and nuclear factor kappa B (NFkappaB) activation, the two ma

237 Early intra-acinar nuclear factor kappa B (NFkappaB) activation, which occu

238 activation, ITCH inhibits NOD2:RIP2-induced nuclear factor kappa B (NFkappaB) activation.

239 in terms of interleukin (IL)-8 promoter and nuclear factor kappa B (NFkappaB) activity, were observe

240 IkappaBalpha enhances the rate of release of nuclear factor kappa B (NFkappaB) from DNA target sites

241 Nuclear factor kappa B (NFkappaB) plays a potential role

242 tion by laminar shear stress is dependent on nuclear factor kappa B (NFkappaB) subunits p50 and p65 b

243 a) is a potent cytokine that signals through nuclear factor kappa B (NFkappaB) to activate a subset o

244 or (TRPV1) and Ca(2+) to microglial IL-6 and nuclear factor kappa B (NFkappaB) translocation with ele

245 The transcription factor, nuclear factor kappa B (NFkappaB), is rapidly activated

246 nt protein deacetylase sirtuin-6 (SIRT6) and nuclear factor kappa B (NFkappaB), sequesters GR express

247 infection of hepatic cells by HCV stimulates nuclear factor kappa B (NFkappaB)-dependent production o

248 n (EMT), but also constitutive activation of nuclear factor kappa B (NFkappaB; RELA).

249 Moreover, LPS induced nuclear factor kappa-B (NFkappaB) activation was enhance

250 ivator of transcription factor 6 (STAT6) and nuclear factor-kappa B (NFkappaB) in mice and cells.

251 onally activated by mTOR complex 2 (mTORC2): nuclear factor-kappa B (NFkappaB) signaling cascade.

252 essing fibroblasts induced the activation of nuclear factor-kappa B (NFkappaB), a regulator fibronect

253 This includes the Nuclear-factor-kappa-B (NFkappaB) pathway, which is cent

254 Nuclear factor kappa B (NFkB) pathway activation represe

255 Streptococcus pneumoniae co-opts the nuclear factor kappa B (NFkB)-regulated proteins polymer

256 ese genes were involved in interferon alpha, nuclear factor-kappa B (NFkB), extracellular signal-rela

257 onase exerts an effect via downregulation of nuclear factor kappa B (NFKbeta) by specific microRNAs (

258 cally regulated by p38delta isoform, whereas nuclear factor kappa B (NFsmall ka, CyrillicB) pathway r

259 the transcriptional level without affecting nuclear factor kappa B nuclear binding.

260 factors, such as glucocorticoid receptor and nuclear factor kappa-b, on the three-dimensional organiz

261 Cs), a phenomenon not mediated by changes to nuclear factor-kappa B or hydrogen sulfide but that occu

262 in the presence of antagonists of NFkappaB (nuclear factor kappa B) or iNOS activity, NO synthesis a

263 factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system involved i

264 ich also correlated with increased levels of nuclear factor kappa B p52 and decreased levels of c-Jun

265 Blocking phosphorylation of nuclear factor kappa B p65 on Ser536 inhibited the emerg

266 iated genes and drove hyperactivation of the nuclear factor kappa B p65 pathway.

267 a4beta1, which resulted in signaling through nuclear factor kappa B p65, protein kinase B1, and p38 m

268 vo that depends on Ser536 phosphorylation of nuclear factor kappa B p65; this pathway may hold valuab

269 -0.59 (-0.8, -0.3) mmol/L; P < 0.001], total nuclear factor kappa-B p65 [-0.016 (-0.022, -0.011) comp

270 t induces expression of ZEB1 by a NF-kappaB (nuclear factor kappa B) p65-dependent mechanism.

271 e pathway that, together with the Rho-kinase nuclear factor kappa B pathway (NF-kB), are required for

272 om platelets, particularly those part of the nuclear factor kappa B pathway, are associated with BMI,

273 s) induced the expression of EMT traits, the nuclear factor kappa B pathway, autophagy, and the loss

274 tors were found to inactivate members of the nuclear factor kappa B pathway.

275 ied activating mutations in the noncanonical nuclear factor-kappa B pathway could give rise to ibruti

276 as 18q21 amplification or activation of the nuclear factor-kappa B pathway, as reported previously,

277 of the mitogen-activated protein kinase and nuclear factor kappa B pathways in MDSCs was MyD88 depen

278 rough regulating the activation of canonical nuclear factor kappa B, phosphatidylinositol-4,5-bisphos

279 phosphoinositide 3-kinase/phosphorylated Akt/nuclear factor kappa B (PI3K/pAkt/NFkappaB)-signaling pa

280 e immune system signaling pathways including nuclear factor-kappa B profoundly alter intestinal epith

281 Chronic alcohol consumption inhibited the nuclear factor kappa B proinflammatory cytokine pathway

282 ease (p<0.01) in the level of phosphorylated-nuclear factor kappa B protein.

283 es to determine the levels of phosphorylated nuclear factor kappa B protein.

284 id-state nanopore has been used to recognize Nuclear Factor-kappa B proteins (NF-kappaB), that are in

285 lonal antibody against receptor activator of nuclear factor kappa B (RANK) ligand, with zoledronic ac

286 omeostatic conditions, receptor activator of nuclear factor kappa-B (RANK) ligand on osteoblasts driv

287 uent bone loss via the receptor activator of nuclear factor-kappa B (RANK)-RANK ligand (RANKL)-osteop

288 f clinical parameters, receptor activator of nuclear factor kappa-B (RANKL) and osteoprotegerin (OPG)

289 on and location of the receptor activator of nuclear factor-kappa B (RANKL) and of osteoprotegerin (O

290 eractions, such as the receptor activator of nuclear factor-kappa B-receptor activator of nuclear fac

291 d transcription factors, such as Bcl-2, Bax, nuclear factor kappa B, regulate the decision-making pow

292 s, cell cycle regulators, as well as p53 and nuclear factor-kappa B-responsive gene targets.

293 occurs through direct targeting of upstream nuclear factor kappa B signal transducers caspase recrui

294 es the proinflammatory transcription factors nuclear factor-kappa B, signal transducer and activators

295 owing C. parvum infection could activate the nuclear factor kappa B signaling pathway and trigger inf

296 l infections, including interferon (IFN) and nuclear factor kappa B signaling.

297 K/NFkappaB (mitogen-activated protein kinase/nuclear factor-kappa B) signals participate in regulatin

298 -responsive element (HRE)) and inflammation (nuclear factor kappa B) to obtain a chimeric promoter na

299 diac tumor necrosis factor-alpha expression, nuclear factor kappa B translocation, obesity-induced pe

300 ession of TWEAK increased, the activation of nuclear factor-kappa B without affecting the activation